These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33878306)

  • 1. Urogenital schistosomiasis in Nigeria post receipt of the largest single praziquantel donation in Africa.
    Enabulele EE; Platt RN; Adeyemi E; Agbosua E; Aisien MSO; Ajakaye OG; Ali MU; Amaechi EC; Atalabi TE; Auta T; Awosolu OB; Dagona AG; Edo-Taiwo O; Ejikeugwu CEP; Igbeneghu C; Njom VS; Orji MN; Oyinloye FOP; Ozemoka HJ; Ugah UI; Anderson TJC
    Acta Trop; 2021 Jul; 219():105916. PubMed ID: 33878306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and intensity of genito-urinary schistosomiasis and associated risk factors among junior high school students in two local government areas around Zobe Dam in Katsina State, Nigeria.
    Atalabi TE; Lawal U; Ipinlaye SJ
    Parasit Vectors; 2016 Jul; 9(1):388. PubMed ID: 27388007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endemic status of urogenital schistosomiasis and the efficacy of a single-dose praziquantel treatment in unmapped rural farming communities in Oyo East Local Government Area, Oyo State, Nigeria.
    Odaibo AB; Komolafe AK; Olajumoke TO; Diyan KD; Aluko DA; Alagbe OA; Ajagbe OA; Olarinloye DB
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012101. PubMed ID: 38620032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on the efficacy of praziquantel and albendazole in the treatment of urinary schistosomiasis in Adim, Cross River State, Nigeria.
    Ben SA; Useh MF
    Int Health; 2017 Sep; 9(5):288-293. PubMed ID: 28911129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria.
    Ojo JA; Adedokun SA; Akindele AA; Olorunfemi AB; Otutu OA; Ojurongbe TA; Thomas BN; Velavan TP; Ojurongbe O
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009628. PubMed ID: 34314428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current epidemiological status of urogenital schistosomiasis among primary school pupils in Katsina State, Nigeria: An imperative for a scale up of water and sanitation initiative and mass administration of medicines with Praziquantel.
    Atalabi TE; Adoh SD; Eze KM
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006636. PubMed ID: 29979684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid mapping of urinary schistosomiasis: An appraisal of the diagnostic efficacy of some questionnaire-based indices among high school students in Katsina State, northwestern Nigeria.
    Atalabi TE; Adubi TO; Lawal U
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005518. PubMed ID: 28369090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.
    Touré S; Zhang Y; Bosqué-Oliva E; Ky C; Ouedraogo A; Koukounari A; Gabrielli AF; Bertrand S; Webster JP; Fenwick A
    Bull World Health Organ; 2008 Oct; 86(10):780-7, A. PubMed ID: 18949215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Efficacy of Praziquantel in
    Houmsou RS; Wama BE; Agere H; Uniga JA; Amuta EU; Kela SL
    Sultan Qaboos Univ Med J; 2018 Aug; 18(3):e304-e310. PubMed ID: 30607270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urogenital schistosomiasis in three different water access in the Senegal river basin: prevalence and monitoring praziquantel efficacy and re-infection levels.
    Senghor B; Mathieu-Begné E; Rey O; Doucouré S; Sow D; Diop B; Sène M; Boissier J; Sokhna C
    BMC Infect Dis; 2022 Dec; 22(1):968. PubMed ID: 36581796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the WHO 50% prevalence threshold in school-aged children as indication for treatment of urogenital schistosomiasis in adults in central Nigeria.
    Evans DS; King JD; Eigege A; Umaru J; Adamani W; Alphonsus K; Sambo Y; Miri ES; Goshit D; Ogah G; Richards FO
    Am J Trop Med Hyg; 2013 Mar; 88(3):441-5. PubMed ID: 23382170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period.
    Senghor B; Diaw OT; Doucoure S; Sylla SN; Seye M; Talla I; Bâ CT; Diallo A; Sokhna C
    Parasit Vectors; 2015 Jul; 8():362. PubMed ID: 26156522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urogenital schistosomiasis and associated determinant factors among senior high school students in the Dutsin-Ma and Safana Local Government Areas of Katsina State, Nigeria.
    Atalabi TE; Lawal U; Akinluyi FO
    Infect Dis Poverty; 2016 Aug; 5(1):69. PubMed ID: 27480058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
    Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
    BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
    Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
    Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary schistosomiasis in Ebonyi State, Nigeria from 2006 to 2017.
    Chiamah OC; Ubachukwu PO; Anorue CO; Ebi S
    J Vector Borne Dis; 2019; 56(2):87-91. PubMed ID: 31397382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.